journal article·2023-09

A Reversible NIR‐II Ratiometric Fluorescent Probe for Real‐Time In Vivo ATP Detection

Yunyi Liu, Lu Zhang, Ying Chen, Haitao Sun, Jiajian Chen, Ahmed Mohamed El‐Toni, Aslam Khan, Zuhai Lei, Fan Zhang

Advanced Optical Materials· Volume 11· Issue 17
Publisher page

Abstract

Abstract ATP plays a prominent role in shaping the evolution of immune cell responses to injury, infection, and cancer. However, real‐time monitoring of ATP levels in vivo remains a challenge, due to the lack of reliable tools that work reversibly in deep tissues. Herein, based on the Förster resonance energy transfer (FRET) strategy, a reversible ratiometric second near‐infrared window (NIR‐II) molecular fluorescent probe (CX‐RATP) is designed and synthesized. CX‐RATP exhibits a significant fluorescence ratio change with the existence of 0–10 mM ATP in vitro, which is within the range of physiological and pathological ATP concentrations. Meanwhile, the recognition process can be reversed by apyrase. It can capture the increase and decrease in ATP levels in real time before and after the treatment of acute inflammation. Besides, CX‐RATP is also successfully applied to the hepatocellular carcinoma (HCC) model and achieves in situ imaging of tumor lesions. These results all provide solid proof that CX‐RATP is a powerful tool for in vivo real‐time ATP detection.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adenosine and Purinergic Signaling · Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry State Key Laboratory of Molecular Engineering of Polymers and iChem Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials Fudan University Shanghai 200433 China

State Key Laboratory of Precision Spectroscopy School of Physics and Electronic Science East China Normal University Shanghai 200241 China

Department of Breast Surgery Key Laboratory of Breast Cancer in Shanghai Fudan University Shanghai Cancer Center Shanghai 200032 China

King Abdullah Institute for Nanotechnology King Saud University Riyadh 11451 Saudi Arabia

Key Laboratory of Smart Drug Delivery Ministry of Education School of Pharmacy Fudan University Shanghai 201203 China

Funding

National Natural Science Foundation of China

References (51)

Show source-provided references
1. 10.1126/science.312.5777.115810.1126/science.312.5777.1158 ↗
2. 10.1126/science.105807910.1126/science.1058079 ↗
3. 10.1126/scisignal.aah710710.1126/scisignal.aah7107 ↗
4. 10.1007/BF0092836110.1007/BF00928361 ↗
5. 10.1038/s41568-018-0037-010.1038/s41568-018-0037-0 ↗
6. 10.1158/0008-5472.CAN-11-167410.1158/0008-5472.CAN-11-1674 ↗
7. 10.1172/JCI1096810.1172/JCI10968 ↗
8. 10.1016/j.isci.2020.10176110.1016/j.isci.2020.101761 ↗
9. 10.1038/nri.2016.410.1038/nri.2016.4 ↗
10. 10.1038/nature1308510.1038/nature13085 ↗
11. 10.1007/s10875-010-9440-310.1007/s10875-010-9440-3 ↗
12. 10.1038/nature0724010.1038/nature07240 ↗
13. 10.1152/physrev.00024.200710.1152/physrev.00024.2007 ↗
14. 10.1002/cptc.20190000110.1002/cptc.201900001 ↗
15. 10.1016/j.cclet.2017.09.03210.1016/j.cclet.2017.09.032 ↗
16. 10.1002/ange.20230058010.1002/ange.202300580 ↗
17. 10.1021/acs.analchem.6b0402010.1021/acs.analchem.6b04020 ↗
18. 10.1021/acs.analchem.0c0050610.1021/acs.analchem.0c00506 ↗
19. 10.1002/anie.20180474310.1002/anie.201804743 ↗
20. 10.1016/j.dyepig.2019.10769810.1016/j.dyepig.2019.107698 ↗
21. 10.1039/D2TB00575A10.1039/D2TB00575A ↗
22. 10.1039/C8CC02209G10.1039/C8CC02209G ↗
23. 10.1016/j.snb.2018.10.13510.1016/j.snb.2018.10.135 ↗
24. 10.1021/jacs.0c0077110.1021/jacs.0c00771 ↗
25. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
26. 10.1039/D1CS00307K10.1039/D1CS00307K ↗
27. 10.1002/anie.20180122610.1002/anie.201801226 ↗
28. 10.1002/anie.20200704010.1002/anie.202007040 ↗
29. 10.1021/acs.nanolett.8b0514810.1021/acs.nanolett.8b05148 ↗
30. 10.1038/s41592-022-01394-610.1038/s41592-022-01394-6 ↗
31. 10.1038/nmat447610.1038/nmat4476 ↗
32. 10.1039/C8CS00234G10.1039/C8CS00234G ↗
33. 10.1055/a‐2033‐855710.1055/a‐2033‐8557 ↗
34. 10.1039/D2SC03136A10.1039/D2SC03136A ↗
35. 10.1002/anie.20200998610.1002/anie.202009986 ↗
36. 10.1038/s41467-020-18051-110.1038/s41467-020-18051-1 ↗
37. 10.3390/bios1111043610.3390/bios11110436 ↗
38. 10.1039/C9CS00318E10.1039/C9CS00318E ↗
39. 10.1002/andp.1948437010510.1002/andp.19484370105 ↗
40. 10.1016/j.pharmthera.2005.04.01310.1016/j.pharmthera.2005.04.013 ↗
41. 10.1007/s00216‐00022‐04463‐z10.1007/s00216‐00022‐04463‐z ↗
42. 10.1021/acs.analchem.0c0480410.1021/acs.analchem.0c04804 ↗
43. 10.1016/S0165-6147(99)01293-610.1016/S0165-6147(99)01293-6 ↗
44. 10.3390/ijms1904122210.3390/ijms19041222 ↗
45. 10.1016/j.lfs.2019.05.02010.1016/j.lfs.2019.05.020 ↗
46. 10.1001/jama.282.17.165910.1001/jama.282.17.1659 ↗
47. 10.1038/ncomms436410.1038/ncomms4364 ↗
48. 10.1016/j.biomaterials.2015.01.05310.1016/j.biomaterials.2015.01.053 ↗
49. 10.1016/S0140-6736(18)30010-210.1016/S0140-6736(18)30010-2 ↗
50. 10.1074/jbc.M113.54004710.1074/jbc.M113.540047 ↗
51. 10.18632/oncotarget.1619110.18632/oncotarget.16191 ↗